TRACON Pharmaceuticals Alpha and Beta Analysis

TCONDelisted Stock  USD 1.60  0.55  52.38%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as TRACON Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in TRACON Pharmaceuticals over a specified time horizon. Remember, high TRACON Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to TRACON Pharmaceuticals' market risk premium analysis include:
Beta
2.24
Alpha
(2.12)
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although TRACON Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, TRACON Pharmaceuticals did 2.12  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of TRACON Pharmaceuticals stock's relative risk over its benchmark. TRACON Pharmaceuticals has a beta of 2.24  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TRACON Pharmaceuticals will likely underperform. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

TRACON Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. TRACON Pharmaceuticals market risk premium is the additional return an investor will receive from holding TRACON Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TRACON Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate TRACON Pharmaceuticals' performance over market.
α-2.12   β2.24

TRACON Pharmaceuticals Fundamentals Vs Peers

Comparing TRACON Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TRACON Pharmaceuticals' direct or indirect competition across all of the common fundamentals between TRACON Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as TRACON Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TRACON Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing TRACON Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare TRACON Pharmaceuticals to competition
FundamentalsTRACON PharmaceuticalsPeer Average
Return On Equity-12.77-0.31
Return On Asset-0.2-0.14
Profit Margin0.14 %(1.27) %
Operating Margin(32.12) %(5.51) %
Current Valuation(2.64 M)16.62 B
Shares Outstanding2.68 M571.82 M
Shares Owned By Insiders2.20 %10.09 %

TRACON Pharmaceuticals Opportunities

TRACON Pharmaceuticals Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
TRACON Pharmaceuticals Announces Reverse Stock Split
04/08/2024
2
UPDATE 1-US airlines seek FAA extension of New York minimum flight requirements cuts -letter
04/10/2024
3
Why Medical Properties Trust Shares Are Trading Higher By Around 13 Here Are 20 Stocks Moving Premarket
04/15/2024
4
Insider Trading
05/07/2024
5
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results andProvides Corporate Update
05/14/2024
6
TRACON Pharmaceuticals Inc Q1 2024 Earnings Call Transcript Highlights Strategic ...
05/15/2024
7
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients
06/11/2024
8
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com - Defense World
06/28/2024

About TRACON Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TRACON or other delisted stocks. Alpha measures the amount that position in TRACON Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

TRACON Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of TRACON Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TRACON Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of TRACON Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of TRACON Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of TRACON Pharmaceuticals' management manipulating its earnings.
13th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with TRACON Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in TRACON Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital